Daily non-political popular news in brief.

Jefferson scientists use gene therapy to reverse heart failure in animals

Heart researchers have used gene therapy to reverse heart failure in animals. They used a virus to carry the gene for a protein, S100A1, into the heart cells of rats with heart failure. After 18 weeks, those animals that received the gene therapy had significantly improved heart function compared to animals that did not receive the treatment. In addition, they found that the gene therapy had additive effects to standard heart failure beta-blocker drugs.

Read more »

Keywords: jefferson, scientists, gene, therapy, reverse, heart, failure, animals, scientist, animal

« Previous | Next »

Similar news on "Jefferson scientists use gene therapy to reverse heart failure in animals":

1. Targeting the adrenal gland could be key strategy against heart failure, Jefferson scientists show
   02-18-2007 · EurekAlert!
   Scientists have staved off heart failure in animals by using gene therapy to shut down the adrenal gland's excessive output of fight or flight hormones such as epinephrine and norepinephrine, which forces the heart to pump too hard. Such a novel approach -- targeting the adrenal gland in addition to the heart -- provides a potential new strategy against heart failure, and could lead to a new class of drugs.
   Similar news · Read more »
   
2. Jefferson neuroscientists show anti-inflammation molecule helps fight MS-like disease
   11-11-2007 · EurekAlert!
   An immune system messenger molecule that normally helps quiet inflammation could be an effective tool against multiple sclerosis. Neurology researchers at Jefferson Medical College have found that the protein interkeukin-27 (IL-27) helped block the onset or reverse symptoms in animals with an MS-like disease. The results suggest that IL-27 may someday be part of a therapy to temper over-active immune responses, which are thought to be at the heart of MS.
   Similar news · Read more »
   
3. Natural, soy-based substance might help fight MS, Jefferson neuroscientists find
   12-12-2006 · EurekAlert!
   A natural substance made from soy appears to have amazing restorative powers when given to animals with a multiple sclerosis (MS)-like disease. Using an animal model of MS, neurologists at Jefferson Medical College found that giving a substance called Bowmann-Birk Inhibitor Concentrate (BBIC) dramatically improved the animals' ability to move and walk. The scientists say the treatment’s effects may be useful in conjunction with more mainstream therapies such as beta-interferon in helping patients with MS.
   Similar news · Read more »
   
4. Study helps explain origins of cardiac fibrosis in patients with heart disease
   07-29-2007 · EurekAlert!
   A report led by researchers at Beth Israel Deaconess Medical Center (BIDMC) helps explain the origins of cardiac fibrosis, a stiffening of the heart muscle that leads to a variety of cardiac diseases, most notably heart failure. The animal study, which appears today in the Advance Online Publication of Nature Medicine, also demonstrates that a bone morphogenic molecule known as rhBMP7 can reverse the cardiac fibrosis process, offering the possibility of a therapeutic target for this debilitating condition.
   Similar news · Read more »
   
5. New therapy could preserve vessel function after heart attack
   09-10-2007 · EurekAlert!
   Scientists have identified the process that causes blood vessels to constrict during and after a heart attack. They've also demonstrated that delivering a vital molecule that is depleted during this process directly to those blood vessels can reverse damage and help restore blood flow. The medical researchers say these findings have the potential to improve outcomes for patients with acute coronary episodes related to ischemia, and to ameliorate the restriction of blood supply to the heart.
   Similar news · Read more »
   
6. Fat protein cuts blood vessel inflammation, may help heart, Jefferson scientists find
   06-01-2007 · EurekAlert!
   A natural substance from fat cells can protect blood vessels from the damaging effects of inflammation, which contributes to heart disease. Researchers at Jefferson Medical College have shown for the first time in an animal model that the substance - a protein called adiponectin - helps prevent immune system white blood cells from binding to the inside of blood vessel walls. Harnessing adiponectin's properties may help protect against blood vessel damage in patients with obesity and diabetes.
   Similar news · Read more »
   
7. Advance in understanding of blood pressure gene could lead to new treatments
   02-04-2007 · EurekAlert!
   Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
   Similar news · Read more »
   
8. Scientists use gene therapy to improve memory and learning in animals
   11-07-2006 · EurekAlert!
   Stanford University neuroscientists have designed a gene that enhances memory and learning ability in animals under stress. Writing in the November 8 issue of the Journal of Neuroscience, the Stanford team says that the experimental technique might one day lead to new forms of gene therapy that can reduce the severe neurological side effects of steroids, which are prescribed to millions of patients with arthritis, asthma and other illnesses.
   Similar news · Read more »
   
9. Jefferson scientists uncover gene mutation that cuts colon polyps, may suppress cancer
   03-21-2007 · EurekAlert!
   Scientists have found a gene mutation that can dramatically reduce the number of colon polyps that develop, potentially cutting the risk of cancer. Researchers studying mice prone to develop polyps discovered that animals carrying the damaged gene had about 90 percent fewer polyps in the small intestine and colon. Because people with large numbers of polyps are at higher risk for colon cancer, the finding may provide new ways to diagnose, prevent and treat it.
   Similar news · Read more »
   
10. One shot of gene therapy spreads through brain in animal study
    10-08-2007 · EurekAlert!
    By targeting a site in a mouse brain well connected to other areas, researchers successfully delivered a beneficial gene to the entire brain—after one injection of gene therapy. If these results in animals can be realized in people, researchers may have a potential method for gene therapy to treat a host of rare but devastating congenital human neurological disorders, such as Tay-Sachs disease.
    Similar news · Read more »